The C. elegans SoxC protein SEM-2 opposes differentiation factors to promote a proliferative blast cell fate in the postembryonic mesoderm

Development

Volumn 138, Issue 6, 2011, Pages 1033-1043

  Tian, Chenxi ^a   Shi, Herong ^a   Colledge, Clark ^b   Stern, Michael ^c   Waterston, Robert ^b   Liu, Jun ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Bodywall muscle; Differentiation; Hox; M lineage; Mesoderm; PBC; Proliferation; SEM 2; Sex myoblast; SoxC

Indexed keywords

HOX PROTEIN; PROTEIN SEM 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CEH 20; TRANSCRIPTION FACTOR FOZI 1; TRANSCRIPTION FACTOR HLH 1; TRANSCRIPTION FACTOR LIN 39; TRANSCRIPTION FACTOR MAB 5; TRANSCRIPTION FACTOR PBC; TRANSCRIPTION FACTOR SOX; UNCLASSIFIED DRUG;

ARTICLE; BLAST CELL; CAENORHABDITIS ELEGANS; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; INTRON; MESODERM; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; EMBRYO, NONMAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; MESODERM; MODELS, BIOLOGICAL; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SOXC TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

CAENORHABDITIS ELEGANS;

EID: 79955127606     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.062240     Document Type: Article

References (62)

1. Aaboe, M., Birkenkamp-Demtroder, K., Wiuf, C., Sorensen, F. B., Thykjaer, T., Sauter, G., Jensen, K. M., Dyrskjot, L. and Orntoft, T. (2006). SOX4 expression in bladder carcinoma: Clinical aspects and in vitro functional characterization. Cancer Res. 66, 3434-3442.
2. Amin, N. M., Hu, K., Pruyne, D., Terzic, D., Bretscher, A. and Liu, J. (2007). A Zn-finger/FH2-domain containing protein, FOZI-1, acts redundantly with cemyod to specify striated body wall muscle fates in the Caenorhabditis elegans postembryonic mesoderm. Development 134, 19-29.
3. Amin, N. M., Lim, S. E., Shi, H., Chan, T. L. and Liu, J. (2009). A conserved sixeya cassette acts downstream of wnt signaling to direct non-myogenic versus myogenic fates in the C. elegans postembryonic mesoderm. Dev. Biol. 331, 350-360.
4. Amin, N. M., Shi, H. and Liu, J. (2010). The FoxF/FoxC factor LET-381 directly regulates both cell fate specification and cell differentiation in C. elegans mesoderm development. Development 137, 1451-1460.
5. Andersson, A., Ritz, C., Lindgren, D., Eden, P., Lassen, C., Heldrup, J., Olofsson, T., Rade, J., Fontes, M., Porwit-Macdonald, A. et al. (2007). Microarray-based classification of a consecutive series of 121 childhood acute leukemias: Prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 21, 1198-1203.
6. Arata, Y., Kouike, H., Zhang, Y., Herman, M. A., Okano, H. and Sawa, H. (2006). Wnt signaling and a hox protein cooperatively regulate Psa-3/Meis to determine daughter cell fate after asymmetric cell division in C. elegans. Dev. Cell 11, 105-115.
7. Argiropoulos, B. and Humphries, R. K. (2007). Hox genes in hematopoiesis and leukemogenesis. Oncogene 26, 6766-6776.
8. Bowles, J., Schepers, G. and Koopman, P. (2000). Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev. Biol. 227, 239-255.
9. Brennan, D. J., Ek, S., Doyle, E., Drew, T., Foley, M., Flannelly, G., O'Connor, D. P., Gallagher, W. M., Kilpinen, S., Kallioniemi, O. P. et al. (2009). The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur. J. Cancer 45, 1510-1517.
10. Broitman-Maduro, G., Maduro, M. F. and Rothman, J. H. (2005). The noncanonical binding site of the MED-1 GATA factor defines differentially regulated target genes in the C. elegans mesendoderm. Dev. Cell 8, 427-433.
11. Chan, S. K. and Mann, R. S. (1996). A structural model for a homeotic proteinextradenticle-DNA complex accounts for the choice of HOX protein in the heterodimer. Proc. Natl. Acad. Sci. USA 93, 5223-5228.
12. Costa, M., Weir, M., Coulson, A., Sulston, J. and Kenyon, C. (1988). Posterior pattern formation in C. elegans involves position-specific expression of a gene containing a homeobox. Cell 55, 747-756.
13. Desai, C., Garriga, G., McIntire, S. L. and Horvitz, H. R. (1988). A genetic pathway for the development of the Caenorhabditis elegans HSN motor neurons. Nature 336, 638-646.
14. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A. and Chinnaiyan, A. M. (2001). Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826.
15. Ernst, T., Hergenhahn, M., Kenzelmann, M., Cohen, C. D., Bonrouhi, M., Weninger, A., Klaren, R., Grone, E. F., Wiesel, M., Gudemann, C. et al. (2002). Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: A gene expression analysis on total and microdissected prostate tissue. Am. J. Pathol. 160, 2169-2180.
16. Foehr, M. L. and Liu, J. (2008). Dorsoventral patterning of the C. elegans postembryonic mesoderm requires both LIN-12/Notch and TGFbeta signaling. Dev. Biol. 313, 256-266.
17. Foehr, M. L., Lindy, A. S., Fairbank, R. C., Amin, N. M., Xu, M., Yanowitz, J., Fire, A. Z. and Liu, J. (2006). An antagonistic role for the C. elegans schnurri homolog SMA-9 in modulating TGFbeta signaling during mesodermal patterning. Development 133, 2887-2896.
18. Friedman, R. S., Bangur, C. S., Zasloff, E. J., Fan, L., Wang, T., Watanabe, Y. and Kalos, M. (2004). Molecular and immunological evaluation of the transcription factor SOX-4 as a lung tumor vaccine antigen. J. Immunol. 172, 3319-3327.
19. Gerstein, M. B., Lu, Z. J., Van Nostrand, E. L., Cheng, C., et al. (2010). Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project. Science 330, 1775-1787.
20. Greenwald, I. S., Sternberg, P. W. and Horvitz, H. R. (1983). The Lin-12 locus specifies cell fates in Caenorhabditis elegans. Cell 34, 435-444.
21. Harfe, B. D. and Fire, A. (1998). Muscle and nerve-specific regulation of a novel NK-2 class homeodomain factor in Caenorhabditis elegans. Development 125, 421-429.
22. Harfe, B. D., Branda, C. S., Krause, M., Stern, M. J. and Fire, A. (1998a). MyoD and the specification of muscle and non-muscle fates during postembryonic development of the C. elegans mesoderm. Development 125, 2479-2488.
23. Harfe, B. D., Vaz Gomes, A., Kenyon, C., Liu, J., Krause, M. and Fire, A. (1998b). Analysis of a Caenorhabditis elegans twist homolog identifies conserved and divergent aspects of mesodermal patterning. Genes Dev. 12, 2623-2635.
24. Jiang, Y., Shi, H., Amin, N. M., Sultan, I. and Liu, J. (2008). Mesodermal expression of the C. elegans HMX homolog mls-2 requires the PBC homolog CEH-20. Mech. Dev. 125, 451-461.
25. Jiang, Y., Shi, H. and Liu, J. (2009). Two Hox cofactors, the Meis/Hth homolog UNC-62 and the Pbx/Exd homolog CEH-20, function together during C. elegans postembryonic mesodermal development. Dev. Biol. 334, 535-546.
26. Kamath, R. S. and Ahringer, J. (2003). Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30, 313-321.
27. Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M. et al. (2003). Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421, 231-237.
28. Kidd, A. R., 3rd, Miskowski, J. A., Siegfried, K. R., Sawa, H. and Kimble, J. (2005). A beta-catenin identified by functional rather than sequence criteria and its role in Wnt/MAPK signaling. Cell 121, 761-772.
29. Kirilly, D., Gu, Y., Huang, Y., Wu, Z., Bashirullah, A., Low, B. C., Kolodkin, A. L., Wang, H. and Yu, F. (2009). A genetic pathway composed of Sox14 and mical governs severing of dendrites during pruning. Nat. Neurosci. 12, 1497-1505.
30. Knoepfler, P. S., Lu, Q. and Kamps, M. P. (1996). Pbx-1 Hox heterodimers bind DNA on inseparable half-sites that permit intrinsic DNA binding specificity of the Hox partner at nucleotides 3_ to a TAAT motif. Nucleic Acids Res. 24, 2288-2294.
31. Koh, K., Peyrot, S. M., Wood, C. G., Wagmaister, J. A., Maduro, M. F., Eisenmann, D. M. and Rothman, J. H. (2002). Cell fates and fusion in the C. elegans vulval primordium are regulated by the EGL-18 and ELT-6 GATA factors-apparent direct targets of the LIN-39 Hox protein. Development 129, 5171-5180.
32. Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U. et al. (2004). Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl. Acad. Sci. USA 101, 811-816.
33. Lee, C. J., Appleby, V. J., Orme, A. T., Chan, W. I. and Scotting, P. J. (2002). Differential expression of SOX4 and SOX11 in medulloblastoma. J. Neurooncol. 57, 201-214.
34. Liu, H., Strauss, T. J., Potts, M. B. and Cameron, S. (2006). Direct regulation of Egl-1 and of programmed cell death by the Hox protein MAB-5 and by CEH-20, a C. elegans homolog of Pbx1. Development 133, 641-650.
35. Liu, J. and Fire, A. (2000). Overlapping roles of two Hox genes and the exd ortholog Ceh-20 in diversification of the C. elegans postembryonic mesoderm. Development 127, 5179-5190.
36. Liu, J., Phillips, B. T., Amaya, M. F., Kimble, J. and Xu, W. (2008). The C. elegans SYS-1 protein is a bona fide beta-catenin. Dev. Cell 14, 751-761.
37. Liu, P., Ramachandran, S., Ali Seyed, M., Scharer, C. D., Laycock, N., Dalton, W. B., Williams, H., Karanam, S., Datta, M. W., Jaye, D. L. et al. (2006). Sexdetermining region Y Box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 66, 4011-4019.
38. Luo, J., Duggan, D. J., Chen, Y., Sauvageot, J., Ewing, C. M., Bittner, M. L., Trent, J. M. and Isaacs, W. B. (2001). Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling. Cancer Res. 61, 4683-4688.
39. Maeda, I., Kohara, Y., Yamamoto, M. and Sugimoto, A. (2001). Large-scale analysis of gene function in Caenorhabditis elegans by high-throughput RNAi. Curr. Biol. 11, 171-176.
40. Magee, J. A., Araki, T., Patil, S., Ehrig, T., True, L., Humphrey, P. A., Catalona, W. J., Watson, M. A. and Milbrandt, J. (2001). Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 61, 5692-5696.
41. Mann, R. S. and Affolter, M. (1998). Hox proteins meet more partners. Curr. Opin. Genet. Dev. 8, 423-429.
42. Mello, C. C., Kramer, J. M., Stinchcomb, D. and Ambros, V. (1991). Efficient gene transfer in C. elegans: Extrachromosomal maintenance and integration of transforming sequences. EMBO J. 10, 3959-3970.
43. Moreno, C. S. (2010). The sex-determining region Y-Box 4 and homeobox C6 transcriptional networks in prostate cancer progression: Crosstalk with the Wnt, Notch, and PI3K pathways. Am. J. Pathol. 176, 518-527.
44. Penzo-Mendez, A. I. (2009). Critical roles for SoxC transcription factors in development and cancer. Int. J. Biochem. Cell Biol. 42, 425-428.
45. Phochanukul, N. and Russell, S. (2010). No backbone but lots of Sox: Invertebrate Sox genes. Int. J. Biochem. Cell Biol. 42, 453-464.
46. Potts, M. B., Wang, D. P. and Cameron, S. (2009). Trithorax, Hox, and TALE-class homeodomain proteins ensure cell survival through repression of the BH3-only gene Egl-1. Dev. Biol. 329, 374-385.
47. Rhodes, D. R., Barrette, T. R., Rubin, M. A., Ghosh, D. and Chinnaiyan, A. M. (2002). Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 62, 4427-4433.
48. Ritter, A. R. and Beckstead, R. B. (2010). Sox14 is required for transcriptional and developmental responses to 20-hydroxyecdysone at the onset of drosophila metamorphosis. Dev. Dyn. 239, 2685-2694.
49. Shah, N. and Sukumar, S. (2010). The Hox genes and their roles in oncogenesis. Nat. Rev. Cancer 10, 361-371.
50. Shemer, G. and Podbilewicz, B. (2002). LIN-39/Hox triggers cell division and represses EFF-1/fusogen-dependent vulval cell fusion. Genes Dev. 16, 3136-3141.
51. Sparkes, A. C., Mumford, K. L., Patel, U. A., Newbury, S. F. and Crane-Robinson, C. (2001). Characterization of an SRY-like gene, DSox14, from Drosophila. Gene 272, 121-129.
52. Sulston, J. E. and Horvitz, H. R. (1977). Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev. Biol. 56, 110-156.
53. Sun, L., Hui, A. M., Su, Q., Vortmeyer, A., Kotliarov, Y., Pastorino, S., Passaniti, A., Menon, J., Walling, J., Bailey, R. et al. (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9, 287-300.
54. Takacs-Vellai, K., Vellai, T., Chen, E. B., Zhang, Y., Guerry, F., Stern, M. J. and Muller, F. (2007). Transcriptional control of Notch signaling by a HOX and a PBX/EXD protein during vulval development in C. elegans. Dev. Biol. 302, 661-669.
55. Talantov, D., Mazumder, A., Yu, J. X., Briggs, T., Jiang, Y., Backus, J., Atkins, D. and Wang, Y. (2005). Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer Res. 11, 7234-7242.
56. Timmons, L. and Fire, A. (1998). Specific interference by ingested dsRNA. Nature 395, 854.
57. Wagmaister, J. A., Miley, G. R., Morris, C. A., Gleason, J. E., Miller, L. M., Kornfeld, K. and Eisenmann, D. M. (2006). Identification of cis-regulatory elements from the C. Elegans Hox gene Lin-39 required for embryonic expression and for regulation by the transcription factors LIN-1, LIN-31 and LIN-39. Dev. Biol. 297, 550-565.
58. Wang, X., Asplund, A. C., Porwit, A., Flygare, J., Smith, C. I., Christensson, B. and Sander, B. (2008). The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: Correlation to overall survival. Br. J. Haematol. 143, 248-252.
59. Warming, S., Costantino, N., Court, D. L., Jenkins, N. A. and Copeland, N. G. (2005). Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33, e36.
60. Wegner, M. (2010). All purpose Sox: The many roles of Sox proteins in gene expression. Int. J. Biochem. Cell Biol. 42, 381-390.
61. Weigle, B., Ebner, R., Temme, A., Schwind, S., Schmitz, M., Kiessling, A., Rieger, M. A., Schackert, G., Schackert, H. K. and Rieber, E. P. (2005). Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. Oncol. Rep. 13, 139-144.
62. Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F., Jr. and Hampton, G. M. (2001). Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978.